EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
Is Eye-Movement Desensitization and Reprocessing (EMDR) Therapy Effective in Children Aged 3 to 6 Years With Trauma-related Disorders or Stressors and Anxiety? A Double-blinded Randomized Controlled Trial.
Promoteur : Fondation Lenval
Titre et résumé fournis en anglais par le registre source, reproduits sans traduction ni interprétation.
This project aims to answer to the question of EMDR effectiveness in young children and to determine whether or not the therapy effectiveness is related to the level of cognitive functioning in young children. The study requires a total of 60 children, girls and boys, aged 3 to 6 years and presenting disorders related to stressors, anxiety and/or trauma. Participants will be randomly distributed in two groups: "EMDR therapy" (N=30) group or "control therapy" (N=30) group. The study will take place in four stages: 1/ Pre-treatment phase : An evaluation of child's various cognitive and executive functions, child's symptomatology and parental distress is planned in a pre-treatment phase. 2/ Treatment phase : An EMDR therapy or a routine care is administered to the child between 6 to 10 weeks. 3/ Post-treatment phase : A reassessment of child's and parent's symptoms is planned at the end of treatment. 4/ Continuation of treatment: Children who have received control therapy and without symptomatic improvement will be proposed EMDR treatment. These children will receive the same symptomatic assessments at the end of EMDR treatment. A significant reduction in disorders related to trauma or stress and anxiety factors and their symptomatology, as well as comorbid disorders and their symptomatology, is expected in children who received EMDR therapy compared to the group who received a control therapy. These results are expected to be robust over a period of at least 3 months. The positive effects of EMDR on child symptomatology are also expected to be more pronounced in children showing higher levels of cognitive functioning
Vous quittez essai-clinique.com pour le site externe clinicaltrials.gov, géré par l’organisme responsable de l’annonce. La candidature, les questions d’éligibilité et toute information médicale se traitent uniquement là-bas.
Important
essai-clinique.com ne recueille pas de candidature et ne détermine pas votre éligibilité. Ne transmettez aucune information médicale au site.
Les critères affichés sont une synthèse des informations disponibles. Seul l’organisme responsable de l’étude peut confirmer l’éligibilité d’une personne.